Company / CapEx per Share
Vivos Therapeutics, Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.01 / $1.00
FY2021-FY2025
Trend
-78.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.00 to $0.10 over the past 2 years.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of +46.9%.
Declined from $1.00 to $0.10 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- +46.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 78.0% year-over-year.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | -78.0% |
| FY2024 | $0.44 | -56.4% |
| FY2023 | $1.00 | +864.0% |
| FY2022 | $0.10 | +1480.0% |
| FY2021 | $0.01 | -53.3% |
| FY2020 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026